In response to the COVID-19 pandemic, the Executive and Education Committees have held separate telecons to mitigate risk to the organization and provide our members helpful, and hopeful, ways to support our integrative community. We recognize that we are all sharing tips, case studies, following newly published studies and helping formulate actions and response to not only our patients, but our staffs and families. In the spirit of our Collaboration Cures partner, AAPMD, we have already sent important updates and resources to our members. With the ongoing and unprecedented interruption of life as we all know it, we hope you find this site and interactive blog format helpful as we encourage you to submit questions and SHARE your experiences.
 
Discussion
Member Discussion ForumNon-Member Inquiry Submission

 
Webinar: eMedTalks series: Making Sense of COVID-19: What We Know and Need to Know to Move Forward

 
Webinar: eMedTalks Series: Update - Coronavirus Impact on Your Life and Health

 
FREE BOOK: Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics
Series Editor
Shailendra K. Saxena
Centre for Advanced Research, King George’s Medical University, Lucknow, India

This book series reviews the recent advancement in the field of medical virology including molecular epidemiology, diagnostics and therapeutic strategies for various
viral infections. The individual books in this series provide a comprehensive overview of infectious diseases that are caused by emerging and re-emerging viruses
including their mode of infections, immunopathology, diagnosis, treatment, epidemiology, and etiology. It also discusses the clinical recommendations in the management of infectious diseases focusing on the current practices, recent advances in diagnostic approaches and therapeutic strategies. The books also discuss progress
and challenges in the development of viral vaccines and discuss the application of viruses in the translational research and human healthcare.
More information about this series at http://www.springer.com/series/16573
 
Naturopathy and Complementary Medicine COVID-19 Support Registry

Please contribute to this registry with de-identified data from patients/clients who have been supported in your practice for COVID-19 exposure or prevention. Distribution of this registry has been approved by the IRB of NUNM, and is supported by the World Naturopathic Federation. Contributions to this registry have been made by researchers at the Canadian College of Naturopathic Medicine, the University of Sydney, the University of Technology, Sydney and the National University of Natural Medicine.

READ MORE HERE

 

We Should Prepare for the Future By Focusing on Us and Not the Virus from Dr. Ahvie Herskowitz, 4/24/2020

According to the USA data today, in all States, the median (mid-range) number of deaths per one-million population is 42 deaths per million (DPM). California is slightly lower at 39 DPM, while NY State has 1,063 or 28 times more than California. So, regional differences require regional solutions.
An example of states restarting their economies include Texas with 20 DPM, South Carolina with 30 DPM, Florida with 47 DPM — they are all fairly low. However, Georgia is the outlier at 85 deaths per million! We hope that Govenor Kemp has made the right decision!
Random antibody testing in New York suggested that 14-21% of people were COVID-19 positive. This means that in the highest testing State of New York, 10-times more people are infected than now known, and the fatality rate is roughly 10 times less, about 0.5%.

The Importance of Pre-existing Conditions:
For the few people that have experienced severe disease and subsequently died, the importance of pre-existing conditions is illustrated below. It is rare to die of COVID-19 without pre-existing conditions.


  • According to the JAMA article "Presenting Characteristics, Comorbidities, and Outcomes Among 5,700 Patients Hospitalized With COVID-19 in the New York City Area," 88% of 5,700 patients hospitalized patients in NYC had greater than one comorbid condition, and half of them had four or more (the highest numbers are with hypertension, diabetes, and obesity); 84% NEVER smoked; only 9% had asthma; and 5% had COPD.
  • This virus does not target patients with pre-existing lung problems, but rather those with pre-existing tendencies towards inflammation.
  • The way the virus enters the body via the ACE-2 receptor explains all of this and gives us our main lesson: THE BEST WAY TO PREPARE FOR THE FUTURE,
    ANY FUTURE, IS TO FOCUS ON US, THE HOSTS, NOT THE VIRUS!!!

 
 Webinar: eMedTalks: COVID-19 Updates and Immunomodulation & Mitochondria

 
 In the USA, the Sky Is NOT Falling! From Dr. Ahvie Herskowitz, 4/9/2020
   
 When we compare USA mortality with the top European countries, this is what we see!When you look at USA State data, this is what we see!We have REGIONAL challenges in the USA, and even in NY, new hospitalizations — but our best measures of future deaths are declining!

Within the USA, the top 10 states with 150 million population have 81% of the total USA deaths (1 per 12,800 persons). Remaining 40 states with 180 million population have 19% of all deaths (1 per 65,800 persons).

With these relatively low-risk numbers in much of the USA, we NEED TO TEST A RANDOM SAMPLING OF THE POPULATION TO UNDERSTAND THE INFECTIVITY RATE! WE NEED TREATMENT OPTIONS! AND WE NEED TO DIVERT RESOURCES TO EMERGING HOT SPOTS LIKE NURSING AND ELDERLY CARE, JAILS AND DETENTION FACILITIES!!

 
  
 Webinar: eMedTalks: COVID-19 Updates and Immune Modulation with MSC Exosomes
Dr. Ahvie Herskowtiz's slides
 
 Updates from Dr. Ahvie Herskowitz 4/7/2020

As you will see below, the strategies include rationale for various natural agents such as vitamin D, vitamin C, vitamin A, zinc, colloidal sliver, melatonin, probiotics, and elderberry as well as drugs such as hydroxychloroquine and Zithromax. The role for stem cells and exosomes as regulators of immune responses to any virus or pathogen, or post-viral autoimmune states is also included.

SCIENCE: Biology of the Coronavirus (SARS-CoV-2) — A Quick Review
ACE2 is not just a doorway for viruses to enter cells.
Similar to its relative, SARS-CoV, which caused the 2003 SARS outbreak, the SARS-CoV-2 virus, enters human cells using an enzyme called angiotensin-converting enzyme 2 (ACE2) as a doorway. ACE2 is found in many tissues but especially high levels in the lung.
Considering the virus uses ACE2 to enter cells there is concern that increasing it may lead to increased risk of infection and severity of COVID-19. However, this is speculation and there is no clinical evidence supporting it. On the contrary, restoring ACE2 levels may be protective.
ACE2 has powerful anti-inflammatory and immune modulating effects but when levels are reduced these beneficial effects are lost. As COVID-19 progresses it causes a state of “ACE2 exhaustion” where ACE2 levels are significantly diminished due to viral particles binding them. Low levels of ACE2 are believed to be responsible for the severe cases of COVID-19 with acute respiratory distress syndrome (ARDS), pneumonia and lung damage. Studies have shown the importance of ACE2 in regards to lung health and underlying conditions that increase the risk of severe COVID-19.

Despite the speculative concern that restoring ACE2 may exacerbate COVID-19, there is ample evidence drawn from previous studies to support its beneficial role. Many natural agents can improve ACE2 and are presented below.

COVID-19 Prevention With Natural Substances, Drugs and Advanced Therapies
There are a number of things you can do to prime your body in case of infection. These are not necessarily treatments but are preventative strategies that may help you reduce risk of infection and support you being part of the 80% with minimal to mild symptoms and a quick recovery. These strategies have the greatest chance of success if they are started before you are exposed.
Conclusion
In addition to the commonly recommended strategies to prevent COVID-19 infection additional measures to support the immune system should be taken, considering that most people in the US are likely to be exposed to SARS-CoV-2 over the next 12 months. Vitamins and minerals including vitamin D, vitamin C, vitamin A, and zinc, along with other natural agents such as curcumin, resveratrol, alpha lipoic acid, melatonin, mushrooms and probiotics may be useful. In addition, stem cells and exosomes may exert added benefit for the prevention of COVID-19.

Read the full update HERE.

 
 Updates from Dr. Ahvie Herskowitz 3/30/2020
Dr. Herskowitz has been educating clients and the national medical community (as President of ACAM) as to the role of modulating our immune systems over the next year, as our “new normal.” Our approach is using IV (intravenous) immune stacks and stem cell therapies, which have been validated in China, Italy, and the USA.
Dr. Herskowitz’s key lessons from COVID-19 is to “fine tune” and optimize, which has been Dr. Herskowitz’s motto for years, as both a trained Cardiologist and Immunologist.
When the overactive immune system attacks a virus, it produces a large number of inflammatory markers over a short period time, which can lead to a severe cytokine storm and subsequent tissue damage. It is believed that the main reason for the lung damage in COVID-19 may be due to this virus induced exaggerated immune response and cytokine storm.
Stem cell IV therapies have been shown to help immunomodulation and, in limited clinical trials, tissue repair and greatly contributed to the improved
outcome of COVID-19 patients, click here.

 COVID-19: Analysis and Predictions for the Beginning of April

Dr. David Ho is a virus expert from Cal Tech who was interviewed ten days ago and published on March 20th. On March 18, there were 8,700 worldwide deaths from COVID19. Today, ten days later, there are over 36,000 deaths — the calculated doubling time worldwide is now every 4.5–5 days.

After we in Europe and the USA reach our respective peaks over the next month, the worldwide numbers will likely be dominated by South America, Africa, the Middle East, and other areas that may remain hidden due to censorship (i.e., Pakistan).

Let’s see what may happen WORLDWIDE in the 1, 2, and 4 week period? Based on a long list of assumptions and the data today, worldwide mortality will likely rise from 36,000 today to 60,000–80,000 in one week and up to 250,000–500,000 worldwide deaths in one month.

WHERE ARE WE IN THE USA?
We may likely see death rates rise from the current roughly 2,800 today to 5,000+ in 7–10 days. The USA remains a small minority of worldwide deaths, but let’s keep this in context of per capita — our mortality rate has remained steady at <2.0% (1.7% today vs worldwide 4.7%) even though the number of USA cases appear to be leading the world.

Every day, we are guided by the data, and reliably predict where hotspots are blossoming and when a region has seen its peak effect for “the first wave.” We can predict these with some level of confidence. While we don’t know how NY State will handle their regional crisis, and how other high-risk regions will fare, more data is suggesting that Hydroxychloroquine and Azithromycin is a very effective therapy. The sooner we gain access and test this combination and other “experimental” therapies to treat symptomatic persons, the faster the surge effect on our medical system will be abated.


View the Source Here

 
  Webinar: 'The Difference a Day Makes"  


 Webinar: Survival For Your Practice and Team: The COVID-19 Challenge

 
 Recent Videos with Ahvie Herskowitz, MD
     

 
 COVID-19 Trends for the USA for Next Week
MARCH 23, 2020

From ACAM President Dr. Ahvie Herskowitz, MD

Our hearts go out to all who are suffering around the globe from COVID-19. As a former New Yorker, I am particularly concerned and upset for our friends and neighbors in NYC and pray for their wellbeing.

As you can see from the chart below, the USA death numbers from WHO are now above 400 (actual numbers from US sources are now above 500, as of this morning). We passed 100 deaths on March 19, as did the United Kingdom; Italy reached this threshold two weeks earlier; France on March 16, and Spain on March 14. The slope of our USA mortality rate is higher than in the United Kingdom (as of today, we have almost doubled their mortality rate).

Based on the European experience, five days from now, we can expect roughly a 5-7 fold increase in deaths in the USA. If we follow in Italy’s footsteps, we will have a 10-fold increase 10-14 days from now. THIS DOES NOT MEAN WE WILL CONTINUE ON THIS PATH MUCH LONGER, SINCE THE INCREASE IN MORTALITY RATES IN ITALY ARE MUCH LOWER THIS PAST WEEK, AS COMPARED TO TWO WEEKS AGO!!!

In California, we are staying more stable, and in San Francisco, our mortality curves remain flat. Let’s hope the same holds true for San Jose, Sacramento, and Los Angeles.

LESSON: Regions that have implemented “Shelter At Home” earlier, seem to be doing better. THIS WORKS!! And in combination with testing and quarantining, THESE IMPLEMENTATIONS REALLY WORK!! LOOK AT KOREA and their incredible data with stable numbers!

 
 COVID-19 Data - The Big Picture
MARCH 22, 2020

From ACAM President Dr. Ahvie Herskowitz, MD and Devin Wilson, ND

In those countries that have suppressed the COVID 19 outbreaks — China, Korea, Japan, Singapore, and Taiwan, there are very few new cases.

Reversal of their local epidemics took roughly 4-8 weeks of diligent care to reduce viral exposures. Mortality rates varied from 4.0% in China to 1.7% in Korea and were primarily seen in the elderly and patients with other pre-existing medical conditions.

Social distancing and expanded testing with isolation worked! Life is now slowly returning to normal in these countries, after a relatively short period. Governments acted, and there are NO signals of any second wave of cases. LESSON: the sooner a country acts, the lesser the burden.

In Europe, like in China, countries that delayed social distancing, mortality rates now reflect overburdened healthcare systems — 8.6% in Italy and 5.3% in Spain.

In the USA, we have regions that electively “locked down” earlier than others Ᾱ SF Bay area acted earlier — a total of 9 deaths (1.6%) vs. NYC’s 44 deaths (5.3%), and Seattle’s 83 deaths (5.4%).

Our USA numbers for confirmed cases (24,142) are not yet meaningful since testing is still not widely available; neither is our low mortality rate of 1.2% (288 total deaths), since our healthcare systems in certain locations (i.e., New York City) are only now coming under great pressure.

We can expect surges in these numbers all over the country and in key states like NY, Washington, Florida, NJ, Illinois, Michigan, Colorado, and Texas.

BUT…

The sooner our entire nation goes into lockdown mode, the faster we will recover! Statistical models demonstrate that the duration will be somewhere in the 3-7 week range.

While younger populations and persons in very good health are unlikely to be seriously injured by this virus, we can all be asymptomatic carriers. The faster we bring down our collective exposures to one another, the quicker we will recover.

Click here for some good news on potential therapies.
 
 Immunosuppression and Patient Variability in Relation to COVID-19
From ACAM President Dr. Ahvie Herskowitz:
Most of the patient variability (how sick do you get) lies in the effect of medical preconditions on immunity… . i.e., the older we are, the more we likely have conditions that reduce our overall immunity. As you can see from the graph, a clear increase in susceptibility to getting very ill and dying from COVID-19 occurs above the age of 50. But, you are probably asking why this should happen at such a young age?

The most likely explanation is that many of us are relatively immunosuppressed due to our inflammatory lifestyle and our levels of circulating Natural Killer Cells (our innate surveillance system) are lower than they should be ... this is the case for most of us, and NOT only for those on steroids or chemotherapy.

But, there is more to a true risk assessment. My early research career at Johns Hopkins emphasized that there is also an immune genetic component — our genetics dictate how each of us will respond to any given virus (in an organized modulated way, or a dysregulated exaggerated way – a sort of "overreaction"). Since the latter is not predictable in advance, modulating our immune systems not to overreact is one key element to staying out of trouble with any potential exposure to COVID-19.

Immunological Arguments for Taking Social Distancing Seriously
From ACAM President Dr. Ahvie Herskowitz:
We have multiple strategies in place for primary prevention — hand washing, social distancing, wearing gloves outdoors, taking vitamins/supplements and keeping our diets healthy, sleeping well, reducing stress and avoiding alcohol — these reduce our risk of getting infected. Since the science of viral infections (whether influenza or our other epidemic of Lyme disease) teaches us, once infected a person cannot predict how their immune response genes will regulate their acute response to any given new virus. This is why small handfuls of 40-something year old patients, who are extremely fit and healthy, have succumbed to COVID-19. This is also why small numbers of patients have died from direct viral mediated heart damage leading to heart failure (and not from respiratory failure). Different patterns of responses are always to be anticipated, and most are not predictable.

But, that is not all. We know that many more people infected will remain asymptomatic, and asymptomatic persons drive community spread. So, is my risk from COVID19 over after I get infected and survive the first 2 months? The answer is no! The end of the virus incubation period may not be the end of organ injury, in that delayed autoimmunity will happen in a significant subset of persons, whether they were initially symptomatic or asymptomatic, way beyond the period that the virus is still infectious.

With this said, the way one avoids infection and modulates their immune response early has long-lasting impact. The use of all the adaptogenic and immune modulating practices bolded above, as well as many others, will down regulate a long-term, chronic stress response. This chronic stress response invites post-viral autoimmune conditions to develop (thyroid, heart, GI tract and liver). Our primary prevention strategies for reducing risk of infection, therefore, also support reducing our risk of post-viral autoimmune disorders after we get infected and “recover”… whether we were asymptomatic or experienced symptoms in early phases. Since our continued immune responses can ultimately lead to post-viral autoimmuity, avoiding the infection is where the smart money is.

Social distancing is the most important tool we have now. Perhaps this will save us from what was surely an inevitable lockdown like in Italy, Spain and France, and probably next in NYC.

 

ACAM HEADQUARTERS
1.800.532.3688 | members@acam.org